Analysis of bacteriological efficacy revealed its most pronounced and clinically significant differences between the groups : the cefotaxime/furamag combination led to higher pathogen eradication in all follow-up periods : after 3 days of treatment ( 82.6 % ) and following a complete therapy cycle ( 95.8 % ) versus the cefotaxime monotherapy group ( 43.5 and 70.8 % , respectively ; p < 0.01 ) .